Table 1.
Proteomics Analysis of FamD2 and FamC1 Expression from in vitro TT-Assay Containing Exogenous Plasmids FamD2 and FamC1, and Substrates 1 and 2 for 12-epi-Hapalindole U 4 Biosynthesisa
FamD2 | FamC1 | ||||
---|---|---|---|---|---|
Total peptide | 20 | Total peptide | 11 | ||
Unique peptide | 20 | Unique peptide | 11 | ||
Coverage (%) | 67.96 | Coverage (%) | 62.11 | ||
Annotated Peptide Sequence | Sequence Positions | PSM FamD2 | Annotated Peptide Sequence | Sequence Position | PSM FamC1 |
[R].IRTDIINVAK.[T] | FamD2 [7–16] | 10 | [K].RTTWTSNNGVGYVGPGTQFYNQLAPEGR.[N] | FamC1 [70–97] | 2 |
[R].TDIINVAK.[T] | FamD2 [9–16] | 6 | [R].TTWTSNNGVGYVGPGTQFYNQLAPEGR.[N] | FamC1 [70–97] | 8 |
[K].TFGAEYSEK.[V] | FamD2 [17–25] | 3 | [R].NIGYIYLSQNPGSGVAGFEQILDATLEPDTK.[Y] | FamC1 [98–128] | 35 |
[K].VLDEVFQVFGEQFADNSFMIR.[T] | FamD2 [26–16] | 19 | [K].YTLTVDVGNLAGTFK.[G] | FamC1 [129–143] | 87 |
[R].TSNKQPDK.[L] | FamD2 [47–54] | 1 | [K]. GLSFAGFPGYR. [V] | FamC1 [144–154] | 19 |
[K].LGCYFR.[Y] | FamD2 [55–60] | 3 | [R].VELLAGDTVLAADHNNLFIK.[E] | FamC1 [155–174] | 306 |
[R].YHEEDESQLGLAWDIAR.[K] | FamD2 [61–77] | 4 | [K].TSTVTYTSTAK. [D] | FamC1 [180–190] | 11 |
[R].KSGLLSDQGRPVDQLIPEICETFPIMADGVDFDVK.[H] | FamD2 [78–112] | 6 | [K].DLHLGQK.[L] | FamC1 [191–197] | 20 |
[K].SGLLSDQGRPVDQLIPEICETFPIMADGVDFD VK. [H] | FamD2 [79–112] | 8 | [R].LVNLLQDK.[F] | FamC1 [202–209] | 2 |
[K].IWQSIK.[G] | FamD2 [118–123] | 3 | [K].FSGLDFDNVR.[L] | FamC1 [210–219] | 15 |
[K].GWPVQDAFK.[L] | FamD2 [124–133] | 5 | [R].LVNLLQDKFSGLDFDNVR. [L] | FamC1 [202–219] | 2 |
[K].LSLPASVTTHSDFLK.[N] | FamD2 [134–148] | 7 | |||
[R].LCFYLPFLNR.[E] | FamD2 [224–233] | 2 | |||
[R].EAVPQNLLNPLLK.[K] | FamD2 [234–246] | 1 | |||
[R].EAVPQNLLNPLLKK.[Y] | FamD2 [234–247] | 2 | |||
[K].KYINEAPALVDNPGFILGWSFGPQGGK.[G] | FamD2 [247–273] | 4 | |||
[K].YINEAPALVDNPGFILGWSFGPQGGK.[G] | FamD2 [248–273] | 2 | |||
[K].VDVDYHGR.[T] | FamD2[279–286] | 1 | |||
[R].TVPLFMK.[V] | FamD2 [287–293] | 1 | |||
[K].VHSQPLPK.[A] | FamD2 [294–301] | 2 | |||
FamD2 | FamC1 | ||||
MNDVNRIRTDIINVAKTFGAEYSEKVLDEVFQVFGEQFADNSFMIRTSNKQPDKLGCYFRYHEEDESQLGLAWDIARKSGLLSDQGRPVDQLIPEICETFPIMADGVDFDVKHGLAKIWQSIKGWPVQDAFKLSLPASVTTHSDFLKNHHLDALYAFGIDYHHSSVNLYFDTYHPKHHTSEYYKNLLQDLQFQPPSDELLELLTNNGEIALTFNFASPRIERLCFYLPFLNREAVPQNLLNPLLKKYINEAPALVDNPGFILGWSFGPQGGKGTYTKVDVDYHGRTVPLFMKVHSQPLPKAADFALAQ, 309 residues | MKRKLIVAVWLIFICLGINTPAHATSAVSIPINNAGFENPFMDWDDYTIDTPPGWTTYDPNNLVPEKRTTWTSNNGVGYVGPGTQFYNQLAPEGRNIGYIYLSQNPGSGVAGFEQILDATLEPDTKYTLTVDVGNLAGTFKGLSFAGFPGYRVELLAGDTVLAADHNNLFIKEGEFKTSTVTYTSTAKDLHLGQKLGIRLVNLLQDKFSGLDFDNVRLTTEPTET, 227 residues |
The sequence highlighted in yellow represents the coverage of the synthesized protein using proteomic analysis.